FIELD: medicine, pharmaceutics.
SUBSTANCE: what is presented is the use of a hybrid macromolecular compound O-(4-(2-(3,4-dihydroxyphenyl)-3,5-dihydroxychroman-4-on-7-yloxy)-4-oxo-butanoyl)-(1→6)-α-D-glucan as a haemorheological agent. What is shown is an ability of the agent to decrease age-related blood viscosity in a hyperviscosity model within a wide range of shear rates; with the compound being characterised by good solubility.
EFFECT: invention extends the range of products improving the blood rheology.
1 tbl
Title | Year | Author | Number |
---|---|---|---|
AGENT IMPROVING RHEOLOGICAL PROPERTIES OF BLOOD | 2013 |
|
RU2546297C1 |
AGENTS EHXIBITING HAEMORHEOLOGIC ACTIVITY | 2010 |
|
RU2425683C1 |
PREPARATIONS IMPROVING SURVIVAL RATE IN WOUND SHOCK | 2011 |
|
RU2471489C1 |
HEMORHEOLOGICAL AGENT | 1998 |
|
RU2141320C1 |
HEMORHEOLOGIC PHYTODRUG | 2012 |
|
RU2471495C1 |
ERYTHROPROTECTIVE AGENT FOR PHENYLHYDRAZINE POISONING | 2011 |
|
RU2471488C1 |
REMEDY HAVING ANTIAGGREGANT ACTIVITY, ACTIVITY DECREASING BLOOD HYPERVISCOSITY AND ANTITHROMBOGENIC ACTIVITY | 2008 |
|
RU2368376C1 |
AGENT ELICITING ANTIAGGREGATIVE AND HEMORHEOLOGICAL ACTIVITY | 2001 |
|
RU2180848C1 |
HEMORHEALOGICAL AGENT | 1998 |
|
RU2150282C1 |
AGENTS WITH HEMORHEOLOGICAL, ANTIAGGREGANT AND ANTITROMBOGENIC ACTIVITY | 2007 |
|
RU2347561C2 |
Authors
Dates
2013-01-27—Published
2011-12-22—Filed